Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment Expedition With MRI Processing and Optimization for Muscle Invasive Bladder Cancer

NCT07067749 is registered in ClinicalTrials.gov with University of Rome Tor Vergata as lead sponsor.

NCT NCT07067749
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07067749 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment Expedition With MRI Processing and Optimization for Muscle Invasive Bladder Cancer
Lead sponsor
University of Rome Tor Vergata
Phase
Phase 3
Overall status
Recruiting
Start date
August 15, 2025
Completion date
August 15, 2030
Enrollment
92 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder (urothelial, transitional cell) cancer, bladder cancer requiring cystectomy, bladder carcinoma, bladder neoplasm, muscle invasive bladder cancer (mibc)